Eliem Therapeutics (NASDAQ: ELYM)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.
The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by SVB Leerink on Monday, July 11, 2022. The analyst firm set a price target for 9.00 expecting ELYM to rise to within 12 months (a possible 210.34% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $2.9 last updated August 9, 2022, 8:00 PM UTC.
There are no upcoming dividends for Eliem Therapeutics.
Eliem Therapeutics’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Eliem Therapeutics.
Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.